MedTrace Logo

Treatment Response to Different Lymphoedema Compression Programs Using a Pneumatic Compression Device

NCT02031627 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2021-07-20

Study results available
· View outcomes & findings →

Summary

Proof of principle study in order to determine if there is a difference in treatment effect across the 3 study groups when treating lower extremity lymphoedema using a pneumatic compression device.

Conditions

  • Lower Extremity Lymphoedema
  • Leg Lymphoedema

Interventions

DEVICE

pneumatic compression - 1 hour per day

Pneumatic compression treatment once per day (1 hour)

DEVICE

pneumatic compression - 2 hours per day

pneumatic compression treatment twice per day in the AM \& PM (2 hours)

DEVICE

pneumatic compression - 4 hours per day

pneumatic compression treatment twice per day consisting of 2 consecutive 1 hour treatments in the AM \& PM (4 hours)

Sponsors & Collaborators

  • Tactile Medical

    lead INDUSTRY

Principal Investigators

  • Vaughan Keeley, PhD, FRCP · Royal Derby Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-11-11
Primary Completion
2019-03-31
Completion
2019-06-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02031627 on ClinicalTrials.gov